FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients with risk factors for biliary stasis/sludge, e.g. preceding major therapy, severe illness and total parenteral nutrition, have increased risk of pancreatitis (see section 4.8).
Slovenian: Bolniki z dejavniki tveganja za zastoj žolča/usedlino, na primer predhodno obsežno zdravljenje, hudo obolenje in hranjenje izključno po parenteralni poti, imajo povečano tveganje za nastanek vnetja trebušne slinavke (glejte poglavje 4.8).
English: If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist.
Slovenian: Če se katerikoli izmed stranskih učinkov razvije v resnega, ali pa če opazite kakršenkoli stranski učinek, ki ni opisan v tem navodilu, vas prosimo, da to poveste svojemu zdravniku, medicinski sestri ali farmacevtu.
English: There is no clear evidence of gallstones or of acute cholecystitis developing in children or infants treated with ceftriaxone, and conservative management of Ceftriaxone precipitate in the gallbladder is recommended.
Slovenian: Ni jasnih dokazov za nastanek žolčnih kamnov ali akutnega holecistitisa pri otrocih ali novorojencih, ki prejemajo ceftriakson, pri oborinah zdravila Ceftriaxone v žolčniku pa se priporoča konservativno zdravljenje.
English: In simultaneous severe renal and hepatic insufficiency the blood ceftriaxone concentrations should be monitored regularly and the dosage adjusted appropriately for children and adults.
Slovenian: • Pri sočasni hudi ledvični in jetrni insuficienci, je treba redno spremljati koncentracije ceftriaksona v krvi, odmerek pa ustrezno prilagoditi otrokom in odraslim.
English: The CHMP agreed also on the following changes to the SPC:
Slovenian: CHMP soglaša tudi z naslednjimi spremembami Povzetka glavnih značilnosti zdravila:
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Cardboard carton
Slovenian: PODATKI, KI SE NAHAJAJO NA ZUNANJI OVOJNINI Karton iz lepenke
English: This can be minimised by slow injection (over 2-4 minutes).
Slovenian: To težavo je mogoče zmanjšati s počasnim injiciranjem (v času od dveh do štirih minut).
English: In infections caused by other bacteria in patients with neutropenic fever interventional treatment with ceftriaxone should be combined with an aminoglycoside.
Slovenian: Pri okužbah, povzročenih z drugimi bakterijami pri bolnikih z nevtropenično vročico, je treba intervencijsko zdravljenje s ceftriaksonom kombinirati z aminoglikozidom.
English: Ceftriaxone is an antibiotic, a semisynthetic cephalosporin of the third generation.
Slovenian: Ceftriakson je antibiotik, polsintetični cefalosporin tretje generacije.
English: Monitoring of renal and hepatic function and haematological parameters at regular intervals are indicated during long-term treatment (see section 4.8).
Slovenian: Med dolgotrajnim zdravljenjem je indicirano spremljanje delovanja ledvic in jeter ter hematoloških parametrov v rednih časovnih presledkih (glejte poglavje 4.8).
English: Ceftriaxone is completely absorbed following intramuscular administration with peak plasma concentrations (about 80 mg/l) occurring between 2 and 3 hours after dosing.
Slovenian: Ceftriakson se po intramuskularnem dajanju v celoti resorbira, največje koncentracije v plazmi (približno 80 mg/l) pa so prisotne 2 do 3 ure po dajanju odmerka.
English: Biochemiestrasse 10 6250 Kundl, Austria
Slovenian: Sandoz GmbH Biochemiestrasse 10 6250 Kundl, Avstrija
English: Intramuscular injection (injection into a muscle)
Slovenian: Intramuskularna injekcija (injiciranje v mišico)
English: Children with a bodyweight of 50 kg or more receive the usual adult dosage once daily (see above).
Slovenian: Otroci s telesno težo 50 kg ali več prejmejo običajni odmerek za odrasle enkrat na dan (glej zgoraj).
English: In infections caused by Pseudomonas aeruginosa with proven sensitivity to ceftriaxone a combination with amino-glycosides is warranted to avoid secondary resistance.
Slovenian: Pri okužbah s Pseudomonas aeruginosa z dokazano občutljivostjo na ceftriakson, je primerno kombiniranje z aminoglikozidi, da se tako prepreči sekundarna odpornost.
English: The solutions should be used immediately after their reconstitution.
Slovenian: Pripravljene raztopine je treba uporabiti takoj po pripravi.
English: Dosage and mode of administration should be determined by the severity and site of infection, susceptibility of the causative micro-organism and the patient's age and condition.
Slovenian: Odmerjanje in način dajanja je treba določiti z ozirom na izraženost in mesto okužbe, občutljivost mikroorganizma, ki je okužbo povzročil in pa z ozirom na starost bolnika in njegovo zdravstveno stanje.
English: Immune system disorders
Slovenian: Motnje imunskega sistema
English: Stomatitis, glossitis, anorexia, nausea, emesis, abdominal pain, loose stool or diarrhoea.
Slovenian: Stomatitis, glositis, anoreksija, navzeja, bruhanje, bolečine v trebuhu, mehko blato ali driska.
English: Mycosis of the genital tract.
Slovenian: Mikoza genitalnega trakta.
English: INSTRUCTIONS ON USE [To be completed nationally]
Slovenian: NAVODILA KAR ZADEVA UPORABO [Je treba izpolniti za vsako državo posebej]
English: The Applicant/MAH was asked to discuss the benefit/risk of the different dosage recommendations for newborns, especially regarding the differentiation of newborns up to 14 days of age and from 15 up to 28 days of age and regarding the use of dose in excess of 50 mg/kg/day.
Slovenian: Vlagatelj/imetnik dovoljenja za promet je bil naprošen za razpravo o razmerjih med koristmi in tveganji izhajajočih iz različnih priporočil za odmerjanje pri novorojencih, zlasti glede razlikovanja novorojencev, starih do 14 dni in od 15 do 28 dni, in glede uporabe odmerkov, večjih od 50 mg/kg/dan.
English: Dosage should be determined by the severity and site of infection, susceptibility of the causative micro-organism and the patient's age and condition.
Slovenian: Odmerjanje je treba določiti z ozirom na izraženost in mesto okužbe, občutljivost mikroorganizma, ki je okužbo povzročil in pa z ozirom na starost bolnika in njegovo zdravstveno stanje.
English: Read all of this leaflet carefully before you start using this medicine.
Slovenian: Preden začnete uporabljati zdravilo natančno preberite to navodilo.
English: very common common uncommon rare very rare, including isolated reports
Slovenian: Zelo redki, vključno s posamičnimi poročili
English: Powder for solution for injection - intramuscular administration: The use of ceftriaxone and lidocaine is contraindicated during pregnancy and lactation.
Slovenian: Prašek za raztopino za injiciranje - intramuskularno dajanje: Uporaba ceftriaksona in lidokaina je med nosečnostjo in dojenjem kontraindicirana.
English: Eosinophilia, leucopenia, granulocytopenia.
Slovenian: Eozinofilija, levkopenija, granulocitopenija.
English: 20 - 80 mg/kg maximum: 80 mg/kg once daily
Slovenian: 20 - 80 mg/kg največ: 80 mg/kg enkrat dnevno
English: The solution is injected deeply into the buttocks muscle (intragluteally).
Slovenian: Raztopino se injicira globoko v stegensko mišico (intraglutealno).
English: Any unused injection or infusion solutions should be disposed of.
Slovenian: Vse neporabljene ostanke raztopin za injiciranje ali infundiranje je treba zavreči.
English: People with liver problems do not need the dose reducing unless they have kidney problems as well.
Slovenian: • Pri ljudeh, ki imajo težave z jetri, odmerka ni treba zmanjševati, razen v primeru, če imajo obenem tudi težave z delovanjem ledvic.
English: Ceftriaxone Tyrol Pharma 1g should not be used by intramuscular injection o in infants under 2 years of age and o during pregnancy and lactation
Slovenian: • Ceftriaxone Tyrol Pharma 1 g se v obliki intramuskularne injekcije ne sme uporabljati - pri otrocih, mlajših od dveh let in - med nosečnostjo in dojenjem
English: The content of the 1g injection vial is dissolved completely in 3.5 ml of 1% lidocaine hydrochloride solution for injection by swirling (concentration 0.3 g/ml).
Slovenian: Vsebino viale se z vrtinčenjem popolnoma raztopi v 3,5 ml 1% raztopine lidokainijevega klorida za injiciranje (koncentracija 0,3 g/ml).
English: In new-born infants 0 - 14 days of age the dose should not exceed 50 mg/kg/24 h.
Slovenian: Pri novorojencih, starih od 0 do 14 dni, odmerek ne sme preseči 50 mg/kg/24 h.
English: In patients on continuous ambulatory peritoneal dialysis (CAPD), ceftriaxone may be administered either intravenously or in case of CAPD associated infections may be added directly to the dialysis solution (e.g. 1-2 g ceftriaxone in the first dialysis fluid of the respective day of treatment) (see section
Slovenian: Pri bolnikih na neprekinjeni ambulantni peritonealni dializi (NAPD) se ceftriakson lahko daje bodisi intravensko, ali pa se, v primeru okužb, povezanih z NAPD, lahko daje neposredno v dializno raztopino (na primer 1-2 g ceftriaksona v prvo dializno tekočino posameznega dneva zdravljenja) (glejte poglavje 6.6).
English: Children 15 days - 12 years of age < 50 kg
Slovenian: Otroci od 15 dni - 12 let starosti < 50 kg
English: Diarrhoea and fungal infection of the mucous membrane could occur in the breast-fed infant, so that nursing might have to be discontinued.
Slovenian: Pri dojenem otroku se lahko pojavita driska in glivična okužba sluznice, tako da je lahko potrebno prenehati z dojenjem.
English: Ceftriaxone Tyrol Pharma 1g for IV injection is dissolved in water for injections (concentration 0.1 g/ml).
Slovenian: Ceftriaxone Tyrol Pharma 1 g za IV injiciranje se raztopi v vodi za injekcije (koncentracija 0,1 g/ml).
English: Serum levels
Slovenian: Koncentracije v serumu
English: ANNEX II SCIENTIFIC CONCLUSIONS AND GROUNDS FOR AMENDMENT OF THE SUMMARIES OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET PRESENTED BY THE EMEA
Slovenian: DODATEK II ZNANSTVENI ZAKLJUČKI IN PODLAGA ZA DOPOLNITEV POVZETKOV GLAVNIH ZNAČILNOSTI ZDRAVILA, OZNAČEVANJA IN NAVODIL ZA UPORABO, KI JIH JE PREDSTAVILA EVROPSKA AGENCIJA ZA ZDRAVILA
English: infection of the meninges (meningitis)
Slovenian: • okužb možganskih ovojnic (meningitis)
English: Clear type II infusion bottles (50 ml) closed with halogenated isobutene-isoprene-rubber stoppers and aluminium caps with plastic flip-off lids.
Slovenian: Prozorne infuzijske stekleničke iz stekla vrste II (50 ml), zaprte z zamaški iz halogenirane izobutenisoprenske gume in aluminijastimi kapicami s plastičnimi flip-off zaporkami.
English: If too much Ceftriaxone was used than it should be, talk to your doctor straight away or go to the nearest hospital accident and emergency department.
Slovenian: Kaj storiti, če ste uporabili večji odmerek zdravila, kot bi smeli Če je bil uporabljen prevelik odmerek ceftriaksona, se takoj pogovorite s svojim zdravnikom ali pa se napotite v oddelek za nujno medicinsko pomoč najbližje bolnišnice.
English: Strength Pharmaceutical Form Route of administration
Slovenian: Farmacevtska oblika Pot uporabe zdravila
English: There are no other ingredients.
Slovenian: Ne vsebuje pomožnih snovi.
English: Inherently resistant species
Slovenian: Po naravi odporne vrste
English: Keep the container in the outer carton in order to protect from light.
Slovenian: Viale shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: The applicant has presented a number of publications from the literature in order to discuss the rational for deviation from the ICH Guideline on Clinical Investigation of Medicinal Products in the Paediatric Population (CPMP/ICH/2711/99) and the basis of differentiation of 0-14 and 15-28 days instead of the more general definition of neonates as ‘up to 28 days after birth', as well as the different dosing regimens used.
Slovenian: Vlagatelj je v obrazložitev zakaj odstopanja od smernic ICH za klinične preiskave zdravil za pediatrično populacijo (CPMP/ICH/2711/99) in zakaj razlikovanje med novorojenci, starimi od 0 do 14 ter od 15 do 28 dni, namesto bolj splošne opredelitve novorojencev kot "do 28 dni po rojstvu", predložil številne objavljene članke in različne uporabljene režime odmerjanja.
English: Nonetheless it was agreed that ceftriaxone is contraindicated in hyperbilirubinaemic newborn and preterm newborn because in vitro studies have shown that ceftriaxone can displace bilirubin from its binding to serum albumin and bilirubin encephalopathy can possibly develop in these patients.
Slovenian: Kljub temu je bilo doseženo soglasje, da je ceftriakson kontraindiciran pri hiperbilirubinemičnih in prezgodaj rojenih novorojencih, ker so študije in vitro pokazale, da lahko ceftriakson izpodrine bilirubin pri vezavi na serumski albumin, pri teh bolnikih pa se lahko razvije bilirubinska encefalopatija.
English: In severe infections the daily dose of 80 mg per kg bodyweight must not be exceeded, except in meningitis (see section 4.2.: Special dosage recommendations).
Slovenian: Pri hudih okužbah se ne sme preseči dnevnega odmerka 80 mg na kilogram telesne mase, razen pri meningitisu (glejte poglavje 4.2.: Posebna priporočila za odmerjanje).
English: 20 - 50 mg/kg maximum: 50 mg/kg once daily
Slovenian: 20 - 50 mg/kg največ: 50 mg/kg enkrat dnevno
English: This diagnosis should be considered in patients who develop diarrhoea during or following treatment with ceftriaxone (see.
Slovenian: To diagnozo je treba upoštevati pri bolnikih, pri katerih se je pojavila driska med zdravljenjem ali po zdravljenju s ceftriaksonom (glejte poglavje 4.8).
English: In patients with impaired renal function, adjustment of the ceftriaxone dose is not necessary if the hepatic function is normal.
Slovenian: Pri bolnikih z zmanjšanim delovanjem ledvic prilagajanje odmerka ceftriaksona ni potrebno, če je delovanje jeter normalno.
English: In renal insufficiency with a reduced creatinine clearance of < 10 ml/min the daily dose of ceftriaxone should not exceed 2 g in adult patients.
Slovenian: Pri ledvični insuficienci z zmanjšanim očistkom kreatinina v obsegu < 10 ml/min, dnevni odmerek ceftriaksona pri odraslih bolnikih ne sme preseči 2 g.
English: Ask your doctor or pharmacist for advice before you use Ceftriaxone Tyrol Pharma 2g.
Slovenian: Vprašajte svojega zdravnika ali farmacevta za nasvet preden uporabite Ceftriaxone Tyrol Pharma 2 g.
English: Synergistic effects of ceftriaxone and aminoglycosides on certain Gram-negative bacteria have been noted in vitro.
Slovenian: In vitro so opazili sinergistične učinke ceftriaksona in aminoglikozidov na določene Gram-negativne bakterije.
English: Clear type III glass vials (15 ml) closed with halogenated isobutene-isoprene-rubber stoppers and aluminium caps with plastic flip-off lids.
Slovenian: Prozorne viale iz stekla vrste III (15 ml), zaprte z zamaški iz halogenirane izobuten-isoprenske gume in aluminijastimi kapicami s plastičnimi flip-off zaporkami.
English: INFORMATION IN BRAILLE [To be completed nationally]
Slovenian: PODATKI V BRAILLOVI PISAVI [Je treba izpolniti za vsako državo posebej]
English: Pain at the site of injection.
Slovenian: Bolečina na mestu injiciranja.
English: Breakpoints
Slovenian: Prelomne točke
English: Unopened: Keep the container in the outer carton in order to protect from light.
Slovenian: Neodprto zdravilo: Viale shranjujte v zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: Ask your doctor or pharmacist for advice before you use Ceftriaxone Tyrol Pharma 1g.
Slovenian: Vprašajte svojega zdravnika ali farmacevta za nasvet preden uporabite Ceftriaxone Tyrol Pharma 1 g.
English: Subsequent to an intramuscular injection of 1 g of ceftriaxone the serum concentration amounted to 79.2 µg/ml after 1.5 hours, and afterwards 58.2, 35.5 and 7.8 µg/ml at the respective time-points 4, 12 and 24 hours after injection.
Slovenian: Po intramuskularnem injiciranju 1 g ceftriaksona so koncentracije v serumu znašale 79,2 µg/ml po 1.5 ure, nato pa 58,2, 35,5 in 7,8 µg/ml v času 4, 12 in 24 ur po injiciranju.
English: The usual dose is 1 to 2 g of ceftriaxone, administered once a day (every 24 hours).
Slovenian: Običajen odmerek je 1 do 2 g ceftriaksona, ki se ga da enkrat na dan (vsakih 24 ur).
English: Further information
Slovenian: Drugi podatki
English: Symptomatic precipitation of ceftriaxone calcium salt in the gallbladder of children/reversible cholelithiasis in children.
Slovenian: Simptomatsko usedanje ceftriakson-kalcijeve soli v žolčniku pri otrocih / reverzibilen pojav žolčnih kamnov pri otrocih.
English: Gram-negative aerobes
Slovenian: Gram-negativni aerobi
English: The active substance is ceftriaxone disodium 3.5 H2O.
Slovenian: Učinkovina je ceftriakson dinatrij 3,5 H2O.
English: If the condition of the kidney is very poor (creatinine clearance of < 10 ml/min), the daily dose of ceftriaxone should not exceed 2 g in adult patients.
Slovenian: Če je stanje ledvic zelo slabo (očistek kreatinina < 10 ml/min, dnevni odmerek ceftriaksona pri odraslih bolnikih ne sme preseči 2 g.
English: In children, doses greater than 80mg/kg body weight should be avoided - except for meningitis - because of the increased risk of biliary precipitates.
Slovenian: Pri otrocih se je treba izogibati odmerkov, ki so večji od 80 mg/kg telesne mase - razen pri meningitisu - zaradi povečanega tveganja da se v žolču pojavijo usedline.
English: Haemodialysis or peritoneal dialysis
Slovenian: Hemodializa ali peritonealna dializa
English: Ceftriaxone Tyrol Pharma 1g is injected into a vein (intravenous administration); however, it can also be injected into a muscle (intramuscular administration).
Slovenian: Ceftriaxone Tyrol Pharma 1 g se injicira v veno (intravensko dajanje); vendarle pa ga je mogoče injicirati tudi v mišico (intramuskularno dajanje).
English: Hypersensitivity reactions against ceftriaxone tend to occur more frequently in persons with a tendency for any allergic reactions and may occur in all degrees of severity up to anaphylactic shock.
Slovenian: Preobčutljivostne reakcije na ceftriakson se raje pojavljajo pogosteje pri bolnikih, ki so nagnjeni h kakršnimkoli alergijskim reakcijam, lahko pa se pojavijo v vseh stopnjah izraženosti, vse do anafilaktičnega šoka.
English: The usual dose is 1-2 g of ceftriaxone, administered once a day (every 24 hours).
Slovenian: Običajni odmerek je 1-2 g ceftriaksona enkrat na dan (vsakih 24 ur).
English: In vitro studies have shown that ceftriaxone can displace bilirubin from its binding to serum albumin and bilirubin encephalopathy can possibly develop in these patients.
Slovenian: Študije in vitro so pokazale, da lahko ceftriakson izpodrine bilirubin pri vezavi na serumski albumin, pri teh bolnikih pa se lahko razvije bilirubinska encefalopatija.
English: Gram-negative anaerobes
Slovenian: Gram-negativni anaerobi
English: • infections of bones or joints
Slovenian: • okužbe kosti ali sklepov
English: Hypersensitivity to the active substance, to other cephalosporins or to any of the excipients.
Slovenian: Preobčutljivost za učinkovino, druge cefalosporinske antibiotike ali katerokoli izmed pomožnih snovi.
English: Caution should be exercised when prescribing to breast-feeding women.
Slovenian: Previdnost je potrebna kadar se zdravilo predpisuje doječim materam.
English: Ceftriaxone is indicated for perioperative prophylaxis in patients with a certain risk of severe postoperative infections (see section 4.4).
Slovenian: Ceftriakson se uporablja za preprečevanje okužb pri kirurških posegih pri bolnikih pri katerih obstaja določeno tveganje, da pride do hudih okužb po operaciji (glejte poglavje 4.4).
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally]
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM [Glejte Prilogo I - Je treba izpolniti za vsako državo posebej]
English: Rarely severe adverse reactions have been reported in preterm and full-term newborns.
Slovenian: Redko so poročali o hudih neželenih stranskih učinkih pri nedonošenčkih in normalno donošenih novorojenčkih.
English: Injections with ceftriaxone should be used with special caution in patients with allergic diathesis, because hypersensitivity reactions emerge faster and proceed more severely after intravenous injection (see section 4.8).
Slovenian: Injekcije s ceftriaksonom je treba posebej previdno uporabljati pri bolnikih z nagnjenostjo k alergijam, ker se preobčutljivostne reakcije pojavijo hitreje in potekajo bolj izrazito po intravenskem injiciranju (glejte poglavje 4.8).
English: Ceftriaxone does not undergo systemic metabolism but it is broken down in the small intestine by bacterial action.
Slovenian: Biološka pretvorba Ceftriakson se ne presnavlja sistemsko, se pa razgradi v tankem črevesju zaradi delovanja bakterij.
English: Ceftriaxone may precipitate in the gallbladder and kidneys and then be detectable as shadows on ultrasound (see section 4.8).
Slovenian: Ceftriakson se lahko obori v žolčniku in ledvicah, oborina pa je lahko videti kot senca na ultrazvoku (glejte poglavje 4.8).
English: No more than 1 g ceftriaxone should be injected on one side.
Slovenian: Na eno stran se ne sme injicirati več kot 1 g ceftriaksona.
English: Infusions with ceftriaxone should be used with special caution in patients with allergic diathesis, because hypersensitivity reactions emerge faster and proceed more severely after intravenous infusion (see section 4.8).
Slovenian: Infuzije s ceftriaksonom je treba posebej previdno uporabljati pri bolnikih z nagnjenostjo k alergijam, ker se preobčutljivostne reakcije pojavijo hitreje in potekajo bolj izrazito po intravenskem infundiranju (glejte poglavje 4.8).
English: Hyperbilirubinaemic newborns and preterm newborns should not be treated with ceftriaxone.
Slovenian: Novorojenčkov s hiperbilirubinemijo in nedonošenčkov se ne sme zdraviti s ceftriaksonom.
English: Powder for solution for injection - intramuscular administration: The use of ceftriaxone and lidocaine is contraindicated during pregnancy and lactation (see section
Slovenian: Prašek za raztopino za injiciranje - intramuskularno dajanje: Uporaba ceftriaksona in lidokaina je med nosečnostjo in dojenjem kontraindicirana (glejte poglavje 4.3).
English: Gram-positive aerobes
Slovenian: Gram-pozitivni aerobi
English: Gram-positive anaerobes
Slovenian: Gram-pozitivni anaerobi
English: Allergic skin reactions (e.g. dermatitis, urticaria, exanthema), pruritus, oedematous swelling of skin and joints
Slovenian: Alergijjske kožne reakcije (na primer dermatitis, koprivnica, eksantem), srbenje, edematozno otekanje kože in sklepov
English: Pain at the site of infusion.
Slovenian: Bolečina na mestu infundiranja.
English: ANNEX III SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET
Slovenian: PRILOGA III POVZETEK TEMELJNIH ZNAČILNOSTI ZDRAVILA, OZNAČEVANJE IN NAVODILO ZA UPORABO
English: You have ever had a severe allergic reaction to any penicillin - or to an other beta-laktamantibiotic because you might also be allergic to this medicine.
Slovenian: • Ste kadarkoli v preteklosti imeli hudo alergijsko reakcijo na katerikoli penicilin - ali na kakšen drug beta laktamski antibiotik, kajti lahko bi bili alergični tudi na to zdravilo
English: Trigger role of ceftriaxonerelated biliary precipitation cannot be ruled-out.
Slovenian: Sprožilne vloge s ceftriaksonom povezanih žolčnih usedlin ni mogoče izključiti.
English: You have ever had a severe allergic reaction to any sort of penicillin - or to an other beta-laktamantibiotic because you might also be allergic to this medicine.
Slovenian: • Ste kadarkoli v preteklosti imeli hudo alergijsko reakcijo na katerikoli vrsto penicilina - ali na kakšen drug beta-laktamski antibiotik, kajti lahko bi bili alergični tudi na to zdravilo
English: In CSF the peak concentrations of 18 mg/l are achieved, after a 50-100 mg/kg intravenous dose, in about four hours.
Slovenian: V cerebrospinalni tekočini se po dajanju intravenskega odmerka v velikosti 50 do 100 mg/kg največje koncentracije v vrednosti 18 mg/l dosežejo v približno štirih urah.
English: Intravenous injection (injection into a vein)
Slovenian: Intravenska injekcija (injiciranje v veno)
English: Route and method of administration
Slovenian: Način in metoda dajanja
English: Nervous system disorders Uncommon:
Slovenian: Motnje živčnega sistema Občasni: